Overview
Haobing Cai practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Myasthenia Gravis, Neuromyelitis Optica, Transverse Myelitis, and Optic Neuritis.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haobing Cai
Is Haobing Cai a top-rated expert for Myasthenia Gravis?
MediFind is an objective health platform that identifies experts based on real-world data. Haobing Cai is classified as an Experienced expert for Myasthenia Gravis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haobing Cai participate in research or clinical trials?
Yes. Haobing Cai has published 12 articles and abstracts on conditions like Myasthenia Gravis. You can view a list of Haobing Cai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Myasthenia GravisCai isExperienced. Learn about Myasthenia Gravis.
- Neuromyelitis OpticaCai isExperienced. Learn about Neuromyelitis Optica.
- Optic NeuritisCai isExperienced. Learn about Optic Neuritis.
- Transverse MyelitisCai isExperienced. Learn about Transverse Myelitis.